Psychoactive drugs and neurotransmitters: differentiating dopamine and norepinephrine neuronal functions with drugs.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology; D001921:Brain / Q000378:metabolism; D001933:Brain Stem / Q000187:drug effects; D002531:Cerebellum / Q000187:drug effects / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D003192:Compulsive Behavior / Q000187:drug effects; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism; D008526:Medulla Oblongata / Q000378:metabolism; D008636:Mesencephalon / Q000378:metabolism; D009411:Nerve Endings; D009638:Norepinephrine / Q000378:metabolism; D010276:Parasympatholytics / Q000494:pharmacology; D011600:Psychopharmacology; D051381:Rats; D011984:Sensory Receptor Cells / Q000187:drug effects; D009435:Synaptic Transmission; D013788:Thalamus / Q000187:drug effects; D014316:Tritium
D000978:Antiparkinson Agents; D010276:Parasympatholytics; D014316:Tritium; D000661:Amphetamine; D004298:Dopamine; D009638:Norepinephrine